Top

Journal of Diabetes & Metabolic Disorders

Published in:

01-06-2020 | Hyperglycemia | Research article

High-dose thiamine supplementation may reduce resting energy expenditure in individuals with hyperglycemia: a randomized, double – blind cross-over trial

Authors: Fariba Alaei-Shahmiri, Mario J. Soares, Maryam Lahouti, Yun Zhao, Jill Sherriff

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2020

Abstract

Background

Despite the crucial role of thiamine in glucose and energy metabolism pathways, there has been no published study examining the impact of thiamine on energy metabolism in humans.

Objective

To assess the effects of thiamine supplementation on resting energy expenditure (REE) in individuals with hyperglycemia.

Methods

Twelve hyperglycemic patients completed this double-blind, randomized trial, where all participants received both thiamine (300 mg/day) and matched placebo for 6 weeks in a cross-over manner. REE was assessed by indirect calorimetry. Anthropometric measurements, fasting and 2-h plasma glucose, and glucose-induced thermogenesis were also assessed at the beginning and on the completion of each six-week phase.

Results

Participants consuming thiamine supplements experienced a significant decrease in the REE assessed at week six compared to the baseline [mean (SE): 1478.93 (73.62) vs.1526.40 (73.46) kcal/d, p = 0.02], and the placebo arm (p = 0.002). These results did not change significantly after adjusting for the participants’ body weight and physical activity as potential confounders. Six-week intervention had no significant effect on the participants’ body weight or waist circumference, in either supplement or placebo arms (all p values>0.05). However, correlation analysis highlighted significant positive relationships between the changes in REE, and those in fasting (r_s = 0.497, p = 0.019) and 2-h plasma glucose (r_s = 0.498, p = 0.018) during the six-week intervention period.

Conclusion

Supplementation with high-dose thiamine may attenuate REE in patients with impaired glucose regulation. Our findings suggest that the impact of thiamine on REE may in part be explained by improved glycemic control.

Trial registration

Australian New Zealand Clinical Trials Registry ACTRN12611000051943. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000051943

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. https://doi.org/10.1016/j.diabres.2019.107843.CrossRefPubMed

Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813–20. https://doi.org/10.1038/414813a 414813a [pii].CrossRefPubMed

Alaei-Shahmiri F, Zhao Y, Sherriff J. Assessment of vascular function in individuals with hyperglycemia: a cross-sectional study of glucose - induced changes in digital volume pulse. J Diabetes Metab Disord. 2015;14:23. https://doi.org/10.1186/s40200-015-0153-2.CrossRefPubMedPubMedCentral

Nair KS, Webster J, Garrow JS. Effect of impaired glucose tolerance and type II diabetes on resting metabolic rate and thermic response to a glucose meal in obese women. Metabolism. 1986;35(7):640–4.CrossRefPubMed

Basu R, Barosa C, Jones J, Dube S, Carter R, Basu A, et al. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia. J Clin Endocrinol Metab. 2013;98(3):E409–17. https://doi.org/10.1210/jc.2012-3056.CrossRefPubMedPubMedCentral

Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 1999;48(11):2197–203.CrossRefPubMed

Franssila-Kallunki A, Groop L. Factors associated with basal metabolic rate in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35(10):962–6.CrossRefPubMed

Manzetti S, Zhang J, van der Spoel D. Thiamin function, metabolism, uptake, and transport. Biochemistry. 2014;53(5):821–35. https://doi.org/10.1021/bi401618y.CrossRefPubMed

Depeint F, Bruce WR, Shangari N, Mehta R, O'Brien PJ. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chem Biol Interact. 2006;163(1–2):94–112. https://doi.org/10.1016/j.cbi.2006.04.014.CrossRefPubMed

10.

Berrone E, Beltramo E, Solimine C, Ape AU, Porta M. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J Biol Chem. 2006;281(14):9307–13. https://doi.org/10.1074/jbc.M600418200.CrossRefPubMed

11.

La Selva M, Beltramo E, Pagnozzi F, Bena E, Molinatti PA, Molinatti GM, et al. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia. 1996;39(11):1263–8.CrossRefPubMed

12.

Thornalley PJ, Jahan I, Ng R. Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem. 2001;129(4):543–9.CrossRefPubMed

13.

Gonzalez-Ortiz M, Martinez-Abundis E, Robles-Cervantes JA, Ramirez-Ramirez V, Ramos-Zavala MG. Effect of thiamine administration on metabolic profile, cytokines and inflammatory markers in drug-naive patients with type 2 diabetes. Eur J Nutr. 2011;50(2):145–9. https://doi.org/10.1007/s00394-010-0123-x.CrossRefPubMed

14.

Alaei-Shahmiri F, Soares MJ, Zhao Y, Sherriff J. The impact of thiamine supplementation on blood pressure, serum lipids and C-reactive protein in individuals with hyperglycemia: a randomised, double-blind cross-over trial. Diabetes Metab Syndr. 2015. https://doi.org/10.1016/j.dsx.2015.04.014.

15.

Rabbani N, Alam SS, Riaz S, Larkin JR, Akhtar MW, Shafi T, et al. High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia. 2009;52(2):208–12. https://doi.org/10.1007/s00125-008-1224-4.CrossRefPubMed

16.

Alaei Shahmiri F, Soares MJ, Zhao Y, Sherriff J. High-dose thiamine supplementation improves glucose tolerance in hyperglycemic individuals: a randomized, double-blind cross-over trial. Eur J Nutr. 2013;52(7):1821–4. https://doi.org/10.1007/s00394-013-0534-6.CrossRefPubMed

17.

Liu M, Alimov AP, Wang H, Frank JA, Katz W, Xu M, et al. Thiamine deficiency induces anorexia by inhibiting hypothalamic AMPK. Neuroscience. 2014;267:102–13. https://doi.org/10.1016/j.neuroscience.2014.02.033.CrossRefPubMed

18.

World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva. 2006. www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf. Accessed 11 Jun 2008.

19.

Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol. 1949;109(1–2):1–9. https://doi.org/10.1113/jphysiol.1949.sp004363.CrossRefPubMedPubMedCentral

20.

Weyer C, Bogardus C, Pratley RE. Metabolic factors contributing to increased resting metabolic rate and decreased insulin-induced thermogenesis during the development of type 2 diabetes. Diabetes. 1999;48(8):1607–14. https://doi.org/10.2337/diabetes.48.8.1607.CrossRefPubMed

21.

Chow S-C, Shao J, Wang H. Sample size calculations in clinical research. Biostatistics series: Chapman and Hall/CRC; 2008.

22.

Caron N, Peyrot N, Caderby T, Verkindt C, Dalleau G. Energy expenditure in people with diabetes mellitus: a review. Front Nutr. 2016;3:56.CrossRefPubMedPubMedCentral

23.

M-x S, Zhao S, Mao H, Wang Z-j, Zhang X-y, Yi L. Increased BMR in overweight and obese patients with type 2 diabetes may result from an increased fat-free mass. Journal of Huazhong University of Science and Technology [Medical Sciences]. 2016;36(1):59–63.CrossRef

24.

Nawata K, Sohmiya M, Kawaguchi M, Nishiki M, Kato Y. Increased resting metabolic rate in patients with type 2 diabetes mellitus accompanied by advanced diabetic nephropathy. Metabolism. 2004;53(11):1395–8.CrossRefPubMed

25.

Consoli A, Nurjhan N, Capani F, Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes. 1989;38(5):550–7.CrossRefPubMed

26.

Coughlan KA, Valentine RJ, Ruderman NB, Saha AK. AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab Syndr Obes Targets Ther. 2014;7:241.

27.

Huynh MKQ, Kinyua AW, Yang DJ, Kim KW. Hypothalamic AMPK as a regulator of energy homeostasis. Neural Plast. 2016;2016.

28.

Hardie DG, Ashford ML. AMPK: regulating energy balance at the cellular and whole body levels. Physiology. 2014;29(2):99–107. https://doi.org/10.1152/physiol.00050.2013.CrossRefPubMedPubMedCentral

29.

Itani SI, Saha AK, Kurowski TG, Coffin HR, Tornheim K, Ruderman NB. Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase. Diabetes. 2003;52(7):1635–40. https://doi.org/10.2337/diabetes.52.7.1635.CrossRefPubMed

30.

McBride A, Ghilagaber S, Nikolaev A, Hardie DG. The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor. Cell Metab. 2009;9(1):23–34. https://doi.org/10.1016/j.cmet.2008.11.008.CrossRefPubMedPubMedCentral

31.

Tabidi I, Saggerson D. Inactivation of the AMP-activated protein kinase by glucose in cardiac myocytes: a role for the pentose phosphate pathway. Biosci Rep. 2012;32(3):229–39.CrossRefPubMed

32.

Karkabounas S, Papadopoulos N, Anastasiadou C, Gubili C, Peschos D, Daskalou T, et al. Effects of alpha-lipoic acid, carnosine, and thiamine supplementation in obese patients with type 2 diabetes mellitus: a randomized, double-blind study. J Med Food. 2018;21(12):1197–203. https://doi.org/10.1089/jmf.2018.0007.CrossRefPubMed

33.

Wilkinson TJ, Hanger HC, Elmslie J, George PM, Sainsbury R. The response to treatment of subclinical thiamine deficiency in the elderly. Am J Clin Nutr. 1997;66(4):925–8. https://doi.org/10.1093/ajcn/66.4.925.CrossRefPubMed

34.

Smidt LJ, Cremin FM, Grivetti LE, Clifford AJ. Influence of thiamin supplementation on the health and general well-being of an elderly Irish population with marginal thiamin deficiency. J Gerontol. 1991;46(1):M16–22.CrossRefPubMed

35.

Chen S, Vieira A. Body mass index and dietary intake of thiamin: evidence for a sexually dimorphic relation. J Hum Ecol. 2007;15:17–22.

Title: High-dose thiamine supplementation may reduce resting energy expenditure in individuals with hyperglycemia: a randomized, double – blind cross-over trial
Authors: Fariba Alaei-Shahmiri
Mario J. Soares
Maryam Lahouti
Yun Zhao
Jill Sherriff
Publication date: 01-06-2020
Publisher: Springer International Publishing
Keyword: Hyperglycemia
Published in: Journal of Diabetes & Metabolic Disorders / Issue 1/2020
Electronic ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-020-00508-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2020

Effects of thylakoid intake on appetite and weight loss: a systematic review

Anti-diabetic effects of Ficus Asperifolia in Streptozotocin-induced diabetic rats

Evaluation of skin absorption of the Citrullus colocynthis in treatment of type II diabetic patients

The reference value of trabecular bone score (TBS) in the Iranian population

Gongronema latifolium leaf extract modulates hyperglycaemia, inhibits redox imbalance and inflammation in alloxan-induced diabetic nephropathy

The association of tobacco smoking and bone health in the elderly population of Iran: results from Bushehr elderly health (BEH) program

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials